NS
AKTS

NBC Securities’s Aktis Oncology AKTS Stock Holding History

NBC Securities’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
+5,358
New +$110K 0.01% 896

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

NBC Securities's AKTS Position: Q2 2026 in Review

NBC Securities opened a new position in Aktis Oncology (AKTS) in Q2 2026: 5,358 shares worth $173K. The stake represents 0.01% of the portfolio and ranks #896 among its holdings.

8 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • NBC Securities held 5,358 shares of Aktis Oncology worth $173K as of Q2 2026.
  • Aktis Oncology was a new NBC Securities position in Q2 2026.
  • Aktis Oncology made up 0.01% of NBC Securities's portfolio in Q2 2026, its #896 holding.
  • 8 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.